Sido Muncul PT (SIDO)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 342.00 |
|---|---|
| 52-week range | 302.00 – 585.00 |
| Return, 1 month / 3 months | −3.4% / −8.6% |
| Return, 1 year / 3 years | −34.5% / −27.4% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 26.0% |
| Worst drawdown (1 year) | -44.2% |
| Average daily value traded | 9,255.15M IDR |
| Dividend yield | 10.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sido Muncul PT is an Indonesian herbal medicine and pharmaceutical company based in Semarang. It makes traditional jamu preparations and modern herbal health products, including remedies for colds and digestive complaints, sold in sachets, bottles and capsules. Its customers are mainly consumers in Indonesia who use herbal products for everyday health, and its goods reach them through pharmacies, shops and distributors across the country. The company also produces some food and beverage items alongside its herbal lines.
Sido Muncul PT trades under the code SIDO on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sido Muncul PT (SIDO) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 342.00 on 23 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 378 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 34.5% and over the last three months it fell 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.2% | ||
| From 52-week high | -41.0% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.6% | ||
| 6-month return | -31.6% | ||
| 12-month return, skipping the last month | -32.3% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.2% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 9,255.15M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 81 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 10.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | −3.4% |
| 3 months | −8.6% |
| 6 months | −31.6% |
| 1 year | −34.5% |
| 3 years | −27.4% |
| 5 years | −46.5% |
Signals
| 50-day / 200-day average | 349.04 / 423.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | IDR 15.0000 |
| 11 Nov 2025 | IDR 22.0000 |
| 15 May 2025 | IDR 21.0000 |
| 5 Nov 2024 | IDR 18.0000 |
| 28 May 2024 | IDR 18.0000 |
| 1 Nov 2023 | IDR 12.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.